Myovant Sciences Ltd.

FREE EMAIL WATCHDOG

Get free email notifications about news in Myovant Sciences Ltd..

The service is free and you can unsubscribe at any time.

General | People (30) | Filings (71) | Annual reports (1) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001679082

Myovant Sciences Ltd. is a publicly traded company

Trading symbol: MYOV

News

2017-06-22

Myovant Sciences Ltd (MYOV) Downgraded by Zacks Investment Research to “Sell”
BNB Daily (blog)
Myovant Sciences Ltd logo Zacks Investment Research cut shares of Myovant Sciences Ltd (NASDAQ:MYOV) from a hold rating to a sell rating in a report published on Wednesday.
BB Biotech AG Acquires 110000 Shares of Myovant Sciences Ltd (MYOV) - Chaffey Breeze

2017-06-18

-$0.18 EPS Expected for Myovant Sciences Ltd (MYOV) This Quarter
The Cerbat Gem
Myovant Sciences logo Wall Street analysts expect Myovant Sciences Ltd (NASDAQ:MYOV) to report earnings per share (EPS) of ($0.18) for the current fiscal quarter, Zacks reports.
Myovant Sciences Ltd. (:MYOV) Runs -16.79% For the Week - Concord Register

2017-06-15

Tekla Capital Management LLC Maintains Position in Myovant Sciences Ltd (MYOV)
Sports Perspectives
Myovant Sciences logo Tekla Capital Management LLC held its position in shares of Myovant Sciences Ltd (NASDAQ:MYOV) during the first quarter, according to its most recent Form 13F filing with the SEC.
Myovant Sciences Ltd (MYOV) Stake Raised by RA Capital Management LLC - Transcript Daily

2017-06-12

Myovant Sciences Ltd (MYOV) Expected to Post Earnings of -$0.18 Per Share
The Cerbat Gem
Myovant Sciences logo Equities research analysts expect Myovant Sciences Ltd (NASDAQ:MYOV) to report earnings of ($0.18) per share for the current fiscal quarter, Zacks Investment Research reports.
Myovant Sciences Ltd. Shares See a Change of -9.13% This Week - Concord Register
BB Biotech AG Has $38.78 Million Stake in Myovant Sciences Ltd (MYOV) - Chaffey Breeze

2017-06-03

Myovant Sciences Ltd (MYOV) Receives $19.50 Consensus Target Price from Analysts
The Cerbat Gem
Myovant Sciences logo Myovant Sciences Ltd (NASDAQ:MYOV) has received an average rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat.
Myovant Sciences Ltd (MYOV) Downgraded to "Hold" at Zacks Investment Research - Chaffey Breeze

2017-06-03

Myovant Sciences Ltd (MYOV) Downgraded by Zacks Investment Research to Hold
The Cerbat Gem
Zacks Investment Research downgraded shares of Myovant Sciences Ltd (NASDAQ:MYOV) from a buy rating to a hold rating in a report released on Wednesday, May 3rd.

2017-06-02

Myovant Sciences Ltd (MYOV) Position Increased by BB Biotech AG
Chaffey Breeze
Myovant Sciences logo BB Biotech AG raised its stake in shares of Myovant Sciences Ltd (NASDAQ:MYOV) by 3.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
Myovant Sciences Ltd (MYOV) Cut to Hold at Zacks Investment Research - Sports Perspectives
Williams Partners LP (WPZ) At $39.39 Forms Top; Myovant Sciences Limited (MYOV ... - HuronReport

Myovant Sciences Ltd. address

20-22 BEDFORD ROW
LONDON
WC1R 4JS

Earliest known filing

July 2016

Latest known filing

June 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

Myovant Sciences Ltd. has 71 filings. View Myovant Sciences Ltd. filings.

Annual Reports

Quarterly Reports

Latest company events

People

We have found 30 people related to Myovant Sciences Ltd..